Peptide profile
Leuprolide
Also known as Leuprorelin
GnRH receptor agonist; sustained exposure suppresses gonadotropins
Approved medicines exist
Science, with its context intact.What to knowThe evidence
The evidence
in perspective.
FDA-approved leuprolide products have defined indications and formulations. Their hormone-suppressing effects do not imply suitability for general hormone optimization.
View the supporting source- Research area
- Endocrine
- Biological target or mechanism
- GnRH receptor agonist; sustained exposure suppresses gonadotropins
- Evidence context
- Approved medicines exist
- Availability
- Availability requires pharmacy review
From information to a conversationClinical decisions stay
Clinical decisions stay
with clinical professionals.
This profile is a research reference. Your prescriber and pharmacy assess the relevant clinical and dispensing pathway. Inclusion here is not an offer to sell this compound.
